Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling

The effect of glucagon-like peptide 1(7–36) amide [GLP-l(7–36) amide] on membrane potential, wholecell ATP-sensitive potassium channel (KATP) and Ca2+ currents, cytoplasmic Ca2+ concentration, and exocytosis was explored in single human β-cells. GLP-1(7–36) amide induced membrane depolarization that was associated with inhibition of whole-cell KATP current. In addition, GLP-l(7–36) amide (and forskolin) produced greater than fourfold potentiation of Ca2+-dependent exocytosis. The latter effect resulted in part (40%) from acceleration of Ca2+ influx through voltage-dependent (L-type) Ca2+ channels. More importantly, GLP- 1(7–36) amide (via generation of cyclic AMP and activation of protein kinase A) potentiated exocytosis at a site distal to a rise in the cytoplasmic Ca2+ concentration. Photorelease of caged cAMP produced a two- to threefold potentiation of exocytosis when the cytoplasmic Ca2+ concentrations were clamped at >170 nmol/1. The effect of GLP-1(7–36) amide was antagonized by the islet hormone somatostatin. Similar effects on membrane potential, ion conductances, and exocytosis were observed with glucose-dependent insulinotropic polypeptide (GIP), the second major incretin. The present data suggest that the strong insulinotropic action of GLP-1(7–36) amide and GIP in humans results from its interaction with several proximal as well as distal important regulatory steps in the stimulus-secretion coupling.

[1]  Kim Cooper,et al.  Low access resistance perforated patch recordings using amphotericin B , 1991, Journal of Neuroscience Methods.

[2]  R. Horn,et al.  Muscarinic activation of ionic currents measured by a new whole-cell recording method , 1988, The Journal of general physiology.

[3]  B. Göke,et al.  Interaction of Glucagon‐Like Peptide‐ 1 (7–36)amide and Somatostatin‐14 in RINm5F Cells and in the Perfused Rat Pancreas , 1989, Pancreas.

[4]  L. Eliasson,et al.  Rapid ATP‐Dependent Priming of Secretory Granules Precedes Ca2+ ‐Induced Exocytosis in Mouse Pancreatic B‐Cells , 1997, The Journal of physiology.

[5]  P. Rorsman,et al.  Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms. , 1996, British journal of pharmacology.

[6]  P. Rorsman,et al.  Neurotransmitter-Induced Inhibition of Exocytosis in Insulin-Secreting β Cells by Activation of Calcineurin , 1996, Neuron.

[7]  P. Rorsman,et al.  Glucagon-Like Peptide I Increases Cytoplasmic Calcium in Insulin-Secreting βTC3-Cells by Enhancement of Intracellular Calcium Mobilization , 1995, Diabetes.

[8]  M. Wheeler,et al.  Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. , 1993, Endocrinology.

[9]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[10]  F. Ashcroft,et al.  Voltage‐activated calcium and potassium currents in human pancreatic beta‐cells. , 1991, The Journal of physiology.

[11]  P. Froguel,et al.  Cloning, Functional Expression, and Chromosomal Localization of the Human Pancreatic Islet Glucose-Dependent Insulinotropic Polypeptide Receptor , 1995, Diabetes.

[12]  H. Kiyokawa,et al.  [The pathogenesis of non-insulin dependent diabetes mellitus]. , 1990, Nihon rinsho. Japanese journal of clinical medicine.

[13]  D. Pipeleers,et al.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.

[14]  E. Gylfe,et al.  Crosstalk between the cAMP and inositol trisphosphate-signalling pathways in pancreatic beta-cells. , 1996, Archives of biochemistry and biophysics.

[15]  J. Holst,et al.  Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins. , 1996, European journal of endocrinology.

[16]  M. Nauck,et al.  Gut hormones and diabetes mellitus. , 1992, Diabetes/metabolism reviews.

[17]  J. Habener,et al.  Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.

[18]  P. Rorsman,et al.  Calcium and delayed potassium currents in mouse pancreatic beta‐cells under voltage‐clamp conditions. , 1986, The Journal of physiology.

[19]  J. Habener,et al.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) , 1993, Nature.

[20]  E Neher,et al.  Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Eliasson,et al.  Co‐localization of L‐type Ca2+ channels and insulin‐containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B‐cells. , 1995, The EMBO journal.

[22]  F. Ashcroft,et al.  Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells , 1993, Nature.

[23]  B. Göke,et al.  Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.

[24]  P. Jones,et al.  Regulation of insulin secretion by cAMP in rat islets of Langerhans permeabilised by high‐voltage discharge , 1986, FEBS letters.

[25]  K. Tatemoto,et al.  GLP-1 depolarizes the rat pancreatic β cell in a Na+-dependent manner , 1996, Regulatory Peptides.

[26]  G. Korbutt,et al.  Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. , 1992, The Journal of clinical investigation.

[27]  J. Holst,et al.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.

[28]  F. Ashcroft,et al.  Exocytosis elicited by action potentials and voltage‐clamp calcium currents in individual mouse pancreatic B‐cells. , 1993, The Journal of physiology.

[29]  B. Thorens.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Rorsman,et al.  Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors , 1997, Pflügers Archiv.

[31]  P. Rorsman,et al.  Stimulation of cloned human glucagon‐like peptide 1 receptor expressed in HEK 293 cells induces cAMP‐dependent activation of calcium‐induced calcium release , 1995, FEBS letters.

[32]  J. Gromada,et al.  Protein Kinase A-Dependent Stimulation of Exocytosis in Mouse Pancreatic β-Cells by Glucose-Dependent Insulinotropic Polypeptide , 1997, Diabetes.